Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Net Cash Flow (2019 - 2025)

Inventiva (IVEVF) posted Net Cash Flow of $93.6 million for Q2 2025, up 279.71% on a QoQ basis from -$52.1 million in Q2 2024, and up 279.71% year-over-year from $24.6 million in Q2 2024.

Analysis

Inventiva (IVEVF) Net Cash Flow (2019 - 2025) Analysis & Trends

Inventiva has reported Net Cash Flow for 6 years, with the latest figure at $93.6 million in Q2 2025.

  • On a quarterly basis, Net Cash Flow rose 279.71% year-over-year to $93.6 million in Q2 2025; TTM through Jun 2025 was $15.6 million, a 116.43% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 94.88% from the prior year.
  • Net Cash Flow was $93.6 million for Q2 2025 at Inventiva, up from -$52.1 million in the prior quarter.
  • The five-year high for Net Cash Flow was $93.6 million in Q2 2025, with the low at -$52.1 million in Q2 2024.
  • Average Net Cash Flow over 4 years is -$2.8 million, with a median of -$13.1 million recorded in 2022.
  • The sharpest annual moves came in 2021 and 2025: Net Cash Flow slumped 393.93% in 2021, then soared 279.71% in 2025.
  • Over 4 years, Net Cash Flow stood at -$17.2 million in 2021, then rose by 25.56% to -$12.8 million in 2022, then sank by 307.0% to -$52.1 million in 2024, then jumped by 279.71% to $93.6 million in 2025.
  • The last three Net Cash Flow figures came in at $93.6 million (Q2 2025), -$52.1 million (Q2 2024), and -$12.8 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Johnson & Johnson 645.04 Bn 624.28 Bn 17.26 Bn -1.27 Bn
2 AbbVie 440.25 Bn 433.68 Bn 12.70 Bn -2.82 Bn
3 Merck 365.65 Bn 358.51 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 266.64 Bn 258.95 Bn 11.24 Bn 757.00 Mn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -722.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 918.27 Mn
7 Revolution Medicines 44.19 Bn 44.19 Bn - 374.50 Mn
8 Incyte 25.29 Bn 20.75 Bn 1.57 Bn 521.33 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 523.50 Mn
10 Inventiva 693.72 Mn 693.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 93.56 Mn
Jun 30, 2024 -52.06 Mn
Dec 31, 2022 -12.79 Mn
Sep 22, 2022 -13.08 Mn
Dec 31, 2021 -17.18 Mn
Jun 30, 2021 -20.66 Mn
Mar 31, 2021 2.58 Mn
Dec 31, 2020 19.59 Mn
Jun 30, 2020 7.03 Mn
Mar 31, 2020 12.20 Mn
Dec 31, 2019 -21.72 Mn